84 related articles for article (PubMed ID: 21046227)
21. Polymorphisms involved in the miR-218-LAMB3 pathway and susceptibility of cervical cancer, a case-control study in Chinese women.
Zhou X; Chen X; Hu L; Han S; Qiang F; Wu Y; Pan L; Shen H; Li Y; Hu Z
Gynecol Oncol; 2010 May; 117(2):287-90. PubMed ID: 20163849
[TBL] [Abstract][Full Text] [Related]
22. LFA-1 gene polymorphisms are associated with the sporadic infiltrative duct breast carcinoma in Chinese Han women of Heilongjiang Province.
Fu Z; Jiao M; Zhang M; Xu F; Yuan W; Pang D; Li D
Breast Cancer Res Treat; 2011 May; 127(1):265-71. PubMed ID: 20953905
[TBL] [Abstract][Full Text] [Related]
23. p53 genotypes and haplotypes associated with risk of breast cancer.
Buyru N; Altinisik J; Demokan S; Dalay N
Cancer Detect Prev; 2007; 31(3):207-13. PubMed ID: 17574348
[TBL] [Abstract][Full Text] [Related]
24. Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection.
Qi P; Dou TH; Geng L; Zhou FG; Gu X; Wang H; Gao CF
Hum Immunol; 2010 Jun; 71(6):621-6. PubMed ID: 20188135
[TBL] [Abstract][Full Text] [Related]
25. Genetic variants in miRNAs predict bladder cancer risk and recurrence.
Wang M; Chu H; Li P; Yuan L; Fu G; Ma L; Shi D; Zhong D; Tong N; Qin C; Yin C; Zhang Z
Cancer Res; 2012 Dec; 72(23):6173-82. PubMed ID: 22846912
[TBL] [Abstract][Full Text] [Related]
26. A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.
Haiman CA; Stram DO; Pike MC; Kolonel LN; Burtt NP; Altshuler D; Hirschhorn J; Henderson BE
Hum Mol Genet; 2003 Oct; 12(20):2679-92. PubMed ID: 12944421
[TBL] [Abstract][Full Text] [Related]
27. Polymorphic variations in exon 10 of the luteinizing hormone receptor: functional consequences and associations with breast cancer.
Piersma D; Verhoef-Post M; Look MP; Uitterlinden AG; Pols HA; Berns EM; Themmen AP
Mol Cell Endocrinol; 2007 Sep; 276(1-2):63-70. PubMed ID: 17709176
[TBL] [Abstract][Full Text] [Related]
28. Human epithelial growth factor receptor 2[Ile655Val] polymorphism and risk of breast fibroadenoma.
Zubor P; Kajo K; Stanclova A; Szunyogh N; Galo S; Dussan CA; Minarik G; Visnovsky J; Danko J
Eur J Cancer Prev; 2008 Feb; 17(1):33-8. PubMed ID: 18090908
[TBL] [Abstract][Full Text] [Related]
29. The role of polymorphisms in circadian pathway genes in breast tumorigenesis.
Dai H; Zhang L; Cao M; Song F; Zheng H; Zhu X; Wei Q; Zhang W; Chen K
Breast Cancer Res Treat; 2011 Jun; 127(2):531-40. PubMed ID: 20978934
[TBL] [Abstract][Full Text] [Related]
30. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
[TBL] [Abstract][Full Text] [Related]
31. Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer.
Zhang Y; Newcomb PA; Egan KM; Titus-Ernstoff L; Chanock S; Welch R; Brinton LA; Lissowska J; Bardin-Mikolajczak A; Peplonska B; Szeszenia-Dabrowska N; Zatonski W; Garcia-Closas M
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):353-8. PubMed ID: 16492928
[TBL] [Abstract][Full Text] [Related]
32. Human microRNAs miR-22, miR-138-2, miR-148a, and miR-488 are associated with panic disorder and regulate several anxiety candidate genes and related pathways.
Muiños-Gimeno M; Espinosa-Parrilla Y; Guidi M; Kagerbauer B; Sipilä T; Maron E; Pettai K; Kananen L; Navinés R; Martín-Santos R; Gratacòs M; Metspalu A; Hovatta I; Estivill X
Biol Psychiatry; 2011 Mar; 69(6):526-33. PubMed ID: 21168126
[TBL] [Abstract][Full Text] [Related]
33. A SNP site in pri-miR-124 changes mature miR-124 expression but no contribution to Alzheimer's disease in a Mongolian population.
Qi L; Hu Y; Zhan Y; Wang J; Wang BB; Xia HF; Ma X
Neurosci Lett; 2012 Apr; 515(1):1-6. PubMed ID: 22430032
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases.
Catucci I; Yang R; Verderio P; Pizzamiglio S; Heesen L; Hemminki K; Sutter C; Wappenschmidt B; Dick M; Arnold N; Bugert P; Niederacher D; Meindl A; Schmutzler RK; Bartram CC; Ficarazzi F; Tizzoni L; Zaffaroni D; Manoukian S; Barile M; Pierotti MA; Radice P; Burwinkel B; Peterlongo P
Hum Mutat; 2010 Jan; 31(1):E1052-7. PubMed ID: 19847796
[TBL] [Abstract][Full Text] [Related]
35. High-resolution melting (HRM) analysis for the detection of single nucleotide polymorphisms in microRNA target sites.
Lin PC; Liu TC; Chang CC; Chen YH; Chang JG
Clin Chim Acta; 2012 Jul; 413(13-14):1092-7. PubMed ID: 22445829
[TBL] [Abstract][Full Text] [Related]
36. ESR1 single nucleotide polymorphism rs1062577 (c.*3804T>A) alters the susceptibility of breast cancer risk in Iranian population.
Dehghan Z; Sadeghi S; Tabatabaeian H; Ghaedi K; Azadeh M; Fazilati M; Bagheri F
Gene; 2017 May; 611():9-14. PubMed ID: 28216037
[TBL] [Abstract][Full Text] [Related]
37. Single nucleotide polymorphism in hsa-mir-196a-2 and breast cancer risk: a case control study.
Jedlinski DJ; Gabrovska PN; Weinstein SR; Smith RA; Griffiths LR
Twin Res Hum Genet; 2011 Oct; 14(5):417-21. PubMed ID: 21962133
[TBL] [Abstract][Full Text] [Related]
38. Genetic variations in the flanking regions of miR-101-2 are associated with increased risk of breast cancer.
Chen J; Qin Z; Jiang Y; Wang Y; He Y; Dai J; Jin G; Ma H; Hu Z; Yin Y; Shen H
PLoS One; 2014; 9(1):e86319. PubMed ID: 24475105
[TBL] [Abstract][Full Text] [Related]
39. The rs12975333 variant in the miR-125a and breast cancer risk in Germany, Italy, Australia and Spain.
Peterlongo P; Caleca L; Cattaneo E; Ravagnani F; Bianchi T; Galastri L; Bernard L; Ficarazzi F; Dall'olio V; Marme F; Langheinz A; Sohn C; Burwinkel B; Giles GG; Baglietto L; Severi G; Odefrey FA; Southey MC; Osorio A; Fernández F; Alonso MR; Benítez J; Barile M; Peissel B; Manoukian S; Radice P
J Med Genet; 2011 Oct; 48(10):703-4. PubMed ID: 21931172
[No Abstract] [Full Text] [Related]
40. ErbB4 receptor polymorphism 2368A>C and risk of breast cancer.
Mansouri Bidkani M; Tabatabaeian H; Parsafar S; Ghanei N; Fazilati M; Ghaedi K
Breast; 2018 Dec; 42():157-163. PubMed ID: 30336339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
